XtalPi Holdings Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 2228.HK | 226330.KQ | CERT | SDGR | SLP | 3759.HK | |
|---|---|---|---|---|---|---|
| Market cap | 27.39B | 23.43B | 1.69B | 2.13B | — | 55.85B |
| P/E (TTM) | — | — | — | — | — | 27.4 |
| Forward P/E | 170.6 | — | 28.3 | -21.1 | — | 17.2 |
| Price/book | 2.6 | — | 1.7 | 5.8 | — | 2.8 |
| Dividend yield | — | — | — | — | — | 0.78% |
| 1-year change | −43.12% | −75.85% | −1.60% | +52.92% | — | +19.72% |
| Today | +4.17% | −1.13% | +2.02% | +4.93% | 0.00% | +3.47% |
The closest companies by business and industry (Health Information Services). Prices may be delayed up to 20 min.
Latest news
All 2228.HK news ›XtalPi collaborates with ASTAR on AI materials discovery in Singapore
Technology firm XtalPi Holdings collaborated with Singapore's Agency for Science, Technology and Research under the MARVEL-AI initiative to accelerate artificial intelligence driven materials science research. XtalPi collaborates with…
XtalPi Partners with A*STAR under MARVEL-AI to Advance AI-Driven Materials Innovation
**media[1283265]**XtalPi joins industry and technology partners to support MARVEL-AI's mission to connect materials discovery with industrial deployment.The collaboration combines XtalPi's AI and laboratory automation capabilities with…
XtalPi Debuts Kodexia™, the World's First Closed-Loop siRNA Platform Combining Generative AI with First-Principles Modeling
This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property strategy into an integrated ...
XtalPi Nominates Its First siRNA Preclinical Candidate for IgA Nephropathy Nine Months After Program Initiation
Preclinical data demonstrate subnanomolar silencing potency, achieving an IC50 tens of times lower than the corresponding values for two clinical-stage... - Preclinical data demonstrate subnanomolar silencing potency, achieving an IC50…
XtalPi Launches AI-Powered Kodexia Platform to Accelerate siRNA Drug Discovery
BioPharma APAC - XtalPi Launches AI-Powered Kodexia Platform to Accelerate siRNA Drug Discovery 07 October 2026 | Wednesday | News - This unified platform integrates sequence design, chemical modification, experimental
XtalPi Unveils Kodexia, a Closed-Loop AI Platform for siRNA Discovery
XtalPi Holdings Limited announced the debut of Kodexia on October 6, 2026, describing it as the industry’s first closed-loop small interfering RNA (siRNA) discovery platform to combine generative AI, first-principles-driven biological…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- biopharmaapac.com1
- manilatimes.net1
- prnewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.